Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

Presentation TCT India 2025

STEMI with Complex Left Main Disease

Presenter: J. Ramakrishna

July 27, 2025

Presentation TCT India 2025

DAPT in STEMI – Do We Have Clarity on Drug, Dose and Duration?

Presenter: Rishi Sethi

July 26, 2025

Presentation AHA 2022

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

Presenter: Gregg W. Stone

November 07, 2022

Presentation TCT 2020

TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI

Presenter: Byeong-Keuk Kim

October 14, 2020

Presentation TCT 2020

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Presenter: George Vlachojannis

October 14, 2020

Presentation SIF 2019

Complete revascularization in STEMI – what shall we do in 2019?

March 29, 2019

Presentation CIT 2018

Optimal Pharmacology and PCI Strategy in STEMI & Multivessel Disease

Presenter: Ran Kornowski

March 23, 2018

Presentation

Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI

October 03, 2017

Presentation iASSESS 2017

STEMI: Treatment Strategies, Drugs And Devices

Presenter: Dharam J. Kumbhani

August 24, 2017

Presentation

Comparative Efficacy and Safety of Reperfusion Therapy With Fibrinolytic Agents in STEMI Patients

August 18, 2017

Presentation

Primary PCI Outcomes in STEMI Patients Treated via Radial Access With Bivalirudin or Heparin

May 23, 2017

Presentation EuroPCR 2017

Prasugrel, Ticagrelor and Clopidogrel in PPCI for STEMI: An Analysis of Comparative Clinical Outcomes from the UK BCIS National Registry

Presenter: Mamas A. Mamas

May 22, 2017

Presentation

FFR-Guided Complete Revascularization in Patients With STEMI and Severe Nonculprit Disease

April 21, 2017

Presentation ESC 2016

PRAGUE-18 Study: Randomized Comparison Of Ticagrelor Versus Prasugrel In STEMI

Presenter: Zuzana Motovska

August 30, 2016

Presentation

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

Presenter: Raffaele Piccolo

August 10, 2016

Presentation CCVVC 2016

Timing of DAPT Interruption and DES Thrombosis

Presenter: Usman Baber

June 16, 2016

Presentation

CRUSH: Crushed Prasugrel Tablets in STEMI Patients Undergoing Primary PCI

Presenter: Fabiana Rollini

March 28, 2016

Presentation

BEAT-AMI: Randomized Control of Sympathetic Drive With Continuous IV Esmolol in Patients With Acute STEMI

Presenter: Fikret Er

February 02, 2016

Presentation

Bivalirudin vs Heparin With or Without GPIs in Patients With STEMI Undergoing Primary PCI

Presenter: Gregg W. Stone

January 05, 2015

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Rod H. Stables

September 14, 2014

Advertisement

STEMI with Complex Left Main Disease

DAPT in STEMI – Do We Have Clarity on Drug, Dose and Duration?

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Complete revascularization in STEMI – what shall we do in 2019?

Optimal Pharmacology and PCI Strategy in STEMI & Multivessel Disease

Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI

STEMI: Treatment Strategies, Drugs And Devices

Comparative Efficacy and Safety of Reperfusion Therapy With Fibrinolytic Agents in STEMI Patients

Primary PCI Outcomes in STEMI Patients Treated via Radial Access With Bivalirudin or Heparin

Prasugrel, Ticagrelor and Clopidogrel in PPCI for STEMI: An Analysis of Comparative Clinical Outcomes from the UK BCIS National Registry

FFR-Guided Complete Revascularization in Patients With STEMI and Severe Nonculprit Disease

PRAGUE-18 Study: Randomized Comparison Of Ticagrelor Versus Prasugrel In STEMI

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

Timing of DAPT Interruption and DES Thrombosis

CRUSH: Crushed Prasugrel Tablets in STEMI Patients Undergoing Primary PCI

BEAT-AMI: Randomized Control of Sympathetic Drive With Continuous IV Esmolol in Patients With Acute STEMI

Bivalirudin vs Heparin With or Without GPIs in Patients With STEMI Undergoing Primary PCI

The Data Strongly Support Heparin!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content